Intraoperative Evaluation of Whole Sentinel Lymph Nodes Using a One-Step Nucleic Acid Amplification Assay in Endometrial Cancer: A Prospective Study

<i>Background and Objectives</i>: The aim of this prospective study was to evaluate the diagnostic accuracy of the one-step nucleic acid amplification (OSNA) assay for the intraoperative assessment of sentinel lymph node (SN) metastases, including micrometastases in patients with stage I...

Full description

Saved in:
Bibliographic Details
Main Authors: Shinichi Togami, Nozomi Furuzono, Mika Mizuno, Hiroaki Kobayashi
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/61/7/1221
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850072202652680192
author Shinichi Togami
Nozomi Furuzono
Mika Mizuno
Hiroaki Kobayashi
author_facet Shinichi Togami
Nozomi Furuzono
Mika Mizuno
Hiroaki Kobayashi
author_sort Shinichi Togami
collection DOAJ
description <i>Background and Objectives</i>: The aim of this prospective study was to evaluate the diagnostic accuracy of the one-step nucleic acid amplification (OSNA) assay for the intraoperative assessment of sentinel lymph node (SN) metastases, including micrometastases in patients with stage IA low-grade endometrial cancer. <i>Materials and Methods</i>: A prospective analysis was conducted on 204 patients with low-risk endometrial cancer who underwent hysterectomy, bilateral salpingo-oophorectomy, and sentinel node navigation surgery. SNs were analyzed intraoperatively using the OSNA assay, and positive patients underwent systematic pelvic lymphadenectomy. <i>Results</i>: Among the 204 patients included, SN metastases were identified in 12 patients (6%), including 10 patients with micrometastases and 2 patients with macrometastases. No metastases were detected in non-SNs in any of the 12 patients. Recurrence occurred in two patients (1%), involving the vaginal stump and pelvic cavity dissemination, but no lymph node recurrence was observed. The OSNA assay identified a proportion of micrometastases in low-risk endometrial cancer. While a direct comparison with conventional pathological ultra-staging was not performed in this study, the detection rate of micrometastases appears higher than that reported in historical controls. <i>Conclusions</i>: This is the first prospective study to evaluate the intraoperative use of the OSNA assay for whole SNs in endometrial cancer. The results suggest that the OSNA assay enhances the detection of micrometastases, enabling a more accurate assessment of SN metastases. In low-risk endometrial cancer, systematic pelvic lymphadenectomy may be safely omitted in patients with SN-positive micrometastases. Further prospective studies are necessary to validate these findings and support the adoption of this approach in clinical practice.
format Article
id doaj-art-d9ab87a886404b3ea8a12a42b2bc556f
institution DOAJ
issn 1010-660X
1648-9144
language English
publishDate 2025-07-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj-art-d9ab87a886404b3ea8a12a42b2bc556f2025-08-20T02:47:07ZengMDPI AGMedicina1010-660X1648-91442025-07-01617122110.3390/medicina61071221Intraoperative Evaluation of Whole Sentinel Lymph Nodes Using a One-Step Nucleic Acid Amplification Assay in Endometrial Cancer: A Prospective StudyShinichi Togami0Nozomi Furuzono1Mika Mizuno2Hiroaki Kobayashi3Department of Obstetrics and Gynecology, Faculty of Medicine, Kagoshima University, Kagoshima 890-8520, JapanDepartment of Obstetrics and Gynecology, Faculty of Medicine, Kagoshima University, Kagoshima 890-8520, JapanDepartment of Obstetrics and Gynecology, Faculty of Medicine, Kagoshima University, Kagoshima 890-8520, JapanDepartment of Obstetrics and Gynecology, Faculty of Medicine, Kagoshima University, Kagoshima 890-8520, Japan<i>Background and Objectives</i>: The aim of this prospective study was to evaluate the diagnostic accuracy of the one-step nucleic acid amplification (OSNA) assay for the intraoperative assessment of sentinel lymph node (SN) metastases, including micrometastases in patients with stage IA low-grade endometrial cancer. <i>Materials and Methods</i>: A prospective analysis was conducted on 204 patients with low-risk endometrial cancer who underwent hysterectomy, bilateral salpingo-oophorectomy, and sentinel node navigation surgery. SNs were analyzed intraoperatively using the OSNA assay, and positive patients underwent systematic pelvic lymphadenectomy. <i>Results</i>: Among the 204 patients included, SN metastases were identified in 12 patients (6%), including 10 patients with micrometastases and 2 patients with macrometastases. No metastases were detected in non-SNs in any of the 12 patients. Recurrence occurred in two patients (1%), involving the vaginal stump and pelvic cavity dissemination, but no lymph node recurrence was observed. The OSNA assay identified a proportion of micrometastases in low-risk endometrial cancer. While a direct comparison with conventional pathological ultra-staging was not performed in this study, the detection rate of micrometastases appears higher than that reported in historical controls. <i>Conclusions</i>: This is the first prospective study to evaluate the intraoperative use of the OSNA assay for whole SNs in endometrial cancer. The results suggest that the OSNA assay enhances the detection of micrometastases, enabling a more accurate assessment of SN metastases. In low-risk endometrial cancer, systematic pelvic lymphadenectomy may be safely omitted in patients with SN-positive micrometastases. Further prospective studies are necessary to validate these findings and support the adoption of this approach in clinical practice.https://www.mdpi.com/1648-9144/61/7/1221endometrial cancermicrometastasisone-step nucleic acid amplificationsentinel lymph node
spellingShingle Shinichi Togami
Nozomi Furuzono
Mika Mizuno
Hiroaki Kobayashi
Intraoperative Evaluation of Whole Sentinel Lymph Nodes Using a One-Step Nucleic Acid Amplification Assay in Endometrial Cancer: A Prospective Study
Medicina
endometrial cancer
micrometastasis
one-step nucleic acid amplification
sentinel lymph node
title Intraoperative Evaluation of Whole Sentinel Lymph Nodes Using a One-Step Nucleic Acid Amplification Assay in Endometrial Cancer: A Prospective Study
title_full Intraoperative Evaluation of Whole Sentinel Lymph Nodes Using a One-Step Nucleic Acid Amplification Assay in Endometrial Cancer: A Prospective Study
title_fullStr Intraoperative Evaluation of Whole Sentinel Lymph Nodes Using a One-Step Nucleic Acid Amplification Assay in Endometrial Cancer: A Prospective Study
title_full_unstemmed Intraoperative Evaluation of Whole Sentinel Lymph Nodes Using a One-Step Nucleic Acid Amplification Assay in Endometrial Cancer: A Prospective Study
title_short Intraoperative Evaluation of Whole Sentinel Lymph Nodes Using a One-Step Nucleic Acid Amplification Assay in Endometrial Cancer: A Prospective Study
title_sort intraoperative evaluation of whole sentinel lymph nodes using a one step nucleic acid amplification assay in endometrial cancer a prospective study
topic endometrial cancer
micrometastasis
one-step nucleic acid amplification
sentinel lymph node
url https://www.mdpi.com/1648-9144/61/7/1221
work_keys_str_mv AT shinichitogami intraoperativeevaluationofwholesentinellymphnodesusingaonestepnucleicacidamplificationassayinendometrialcanceraprospectivestudy
AT nozomifuruzono intraoperativeevaluationofwholesentinellymphnodesusingaonestepnucleicacidamplificationassayinendometrialcanceraprospectivestudy
AT mikamizuno intraoperativeevaluationofwholesentinellymphnodesusingaonestepnucleicacidamplificationassayinendometrialcanceraprospectivestudy
AT hiroakikobayashi intraoperativeevaluationofwholesentinellymphnodesusingaonestepnucleicacidamplificationassayinendometrialcanceraprospectivestudy